July 19, 2016 / 12:07 PM / a year ago

BRIEF-Antibe Therapeutics appoints new board member

July 19 (Reuters) - Antibe Therapeutics :

* Anticipates that final results will be available for release by mid-august

* Antibe Therapeutics Announces The Appointment Of New Board Member And Provides Update On Phase 2 Trial Of Atb-346

* Antibe anticipates that final results will be available for release by mid-august

* Elected to pay in-kind all interest due July 15, 2016 under company's 10% senior secured convertible debentures due October 15, 2018

* Aggregate July 15, 2016 interest payment under debentures in amount of $79,521.56 has been added to principal amount of debentures Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below